BioStock: Breakthrough in the Asia-Pacific region for CLS

Report this content

CLS has received market approval for the TRANBERG portfolio from the Health Sciences Authority in Singapore. According to the company, this represents an important milestone for CLS’s global expansion and opens doors for commercialisation in Singapore, and eventually a broader launch in the Asia-Pacific region.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/01/breakthrough-in-the-asia-pacific-region-for-cls/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: Breakthrough in the Asia-Pacific region for CLS
Tweet this